• money9
  • Insurance
  • Saving
  • Mutual Funds
  • Mirae Asset MF
  • Breaking Briefs
downloadDownload The App
Close
  • Home
  • Videos
  • Podcast
  • Banking
  • Bulletin
  • Gold
  • Healthcare
  • Real Estate
  • Tax
  • Travel
  • Survey 2023
  • Survey Report
  • Breaking Briefs
  • Insurance
  • Savings
  • Loan
  • Crypto
  • Investment
  • Mutual Funds
  • Real Estate
  • Tax
  • Exclusive
  • Home » Johnson & Johnson

Johnson & Johnson

  • Exclusive

    Adani’s wait for Dharavi gets longer

    Adani’s wait for Dharavi gets longer; After court win, J&J gives up baby powder licence; Foxconn talking to Taiwan co for chip unit

  • Exclusive

    Johnson & Johnson's single-dose vaccine gets approval

    In April the company had said indicated that it was in discussion with the government about starting a  clinical study for the vaccine.

  • Covid-19

    Johnson & Johnson applies for approval of its single dose Covid-19 vaccine in India

    The Company has also said that Biological E will be an important part of their global supply chain network.

  • Covid Update

    US recommends ‘pause’ for J&J vaccine over clot reports

    The US is recommending a 'pause' in administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangero

Latest

  • 1. Know the correct way to get KYC done!
  • 2. Why health insurance claim gets rejected?
  • 3. Power to Respond!
  • 4. What is Asset Under Management?
  • 5. No Worries on Medical Expenses!
  • Contact Us
  • About Us
  • Privacy & Cookies Notice
  • Complaint Redressal
  • Copyright © 2026 Money9. All rights reserved.
  • share
  • Facebook
  • Twitter
  • Whatsapp
  • LinkedIn
  • Telegram
close